先天性二尖瓣修复术后出院前重大残余病变或非计划再干预风险预测模型的预后效用
该研究在单中心回顾性纳入2000年1月至2020年12月因先天性二尖瓣修复(除外原发修复,包括通道型缺损的二次修复)且存活出院的患者,构建出院前重大二尖瓣残余病变或非计划再干预的风险预测模型。866例患者中202例(23.3%)发生主要结局,最终模型C统计量为0.82(95%CI 0.78-0.85),按加权风险评分分层后低、中、高、极高危患者的主要结局概率分别为5.0±1.7%、15.2±6.7%、45.9±12.6%和76.7±8.8%。作者认为该模型可能有助于先天性二尖瓣修复术后患者的预后判断。
要点
- 866例先天性二尖瓣修复患者中202例(23.3%)发生出院前重大残余病变或非计划再干预。
- 最终风险预测模型C统计量为0.82(95%CI 0.78-0.85),风险评分中位8分(IQR 6-11)。
- 低、中、高、极高危患者主要结局概率分别为5.0±1.7%、15.2±6.7%、45.9±12.6%、76.7±8.8%。
核心结论
- 作者认为该风险预测模型可能有助于先天性二尖瓣修复术后患者的预后判断。
研究设计与样本
- 单中心回顾性研究,纳入2000年1月至2020年12月因先天性二尖瓣修复(除外原发修复,包括通道型缺损的二次修复)且存活出院的患者。
- 共866例患者,修复时中位年龄2.7岁(四分位距0.7-9.1岁)。
- 采用逻辑回归构建主要结局的加权风险评分,并用bootstrap重采样进行内部验证。
主要发现
- 866例患者中202例(23.3%)发生主要结局,即出院超声心动图平均跨瓣压差>6 mm Hg或中度及以上反流,或出院前非计划二尖瓣再干预。
- 最终风险预测模型C统计量为0.82(95%CI 0.78-0.85)。
- 风险评分中位8分(四分位距6-11分),分为低危(0-5分)、中危(6-10分)、高危(11-15分)和极高危(≥16分)。
- 低、中、高、极高危患者主要结局概率分别为5.0±1.7%、15.2±6.7%、45.9±12.6%和76.7±8.8%。
关键数值与推荐
- 主要结局定义:出院超声心动图平均跨瓣压差>6 mm Hg或中度及以上反流,或出院前非计划二尖瓣再干预。
- 风险分层:低危0-5分、中危6-10分、高危11-15分、极高危≥16分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to develop a risk prediction model for predischarge major mitral valve (MV) residual lesions or unplanned MV reinterventions following congenital MV repair. METHODS: Patients who underwent congenital MV repair (excluding primary repair, but including secondary repair, of canal-type defects) at a single institution from January 2000 to December 2020 and survived to discharge were retrospectively reviewed. The primary outcome was major MV residua (mean gradient >6 mm Hg or moderate or greater regurgitation on the discharge echocardiogram) or predischarge unplanned MV reintervention. Risk factors of interest included age, single-ventricle physiology, preoperative and intraoperative postrepair MV stenosis and regurgitation severity, MV annular diameter z score, systemic ventricle ejection fraction, unfavorable anatomy, concomitant left-heart procedure, and various technique-related categories. Logistic regression was used to develop a weighted risk score for the primary outcome. Internal validation using bootstrap-resampling was performed. RESULTS: Of 866 patients who underwent congenital MV repair at a median age of 2.7 years (interquartile range, 0.7-9.1 years), 202 (23.3%) patients developed the primary outcome. The final risk prediction model had a C-statistic of 0.82 (95% confidence interval, 0.78-0.85). A weighted risk score was formulated per the variables in this model. The median risk score was 8 (interquartile range, 6-11) points. Patients were categorized as low (score 0-5), medium (score 6-10), high (score 11-15), or very high (score ≥16) risk. The probability of the primary outcome was 5.0 ± 1.7%, 15.2 ± 6.7%, 45.9 ± 12.6%, and 76.7 ± 8.8% for low-, medium-, high-, and very-high-risk patients, respectively. CONCLUSIONS: Our risk prediction model may guide prognostication of patients following congenital MV repair.
引用
- Sengupta A, Gauvreau K, Lee JM, et al. Prognostic utility of a risk prediction model for predischarge major residual lesions or unplanned reinterventions following congenital mitral valve repair. J Thorac Cardiovasc Surg. 2023. PMID: 37995862. doi:10.1016/j.jtcvs.2023.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。